Truist Financial raised the stock rating for Corcept Therapeutics, and a director sold company stock.
2 reports, 2 independent
Updated Jul 21
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Truist Financial raised the stock rating for Corcept Therapeutics, and a director sold company stock.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Corcept Therapeutics
American pharmaceutical company
Nothing else this week.
-
Truist Financial
American bank holding company, formerly known as BB&T Corporation